Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	204
Overall Study	STARTED	MD-120 50 mg	207
Overall Study	STARTED	MD-120 100 mg	204
Overall Study	Received Treatment	Placebo	204
Overall Study	Received Treatment	MD-120 50 mg	206
Overall Study	Received Treatment	MD-120 100 mg	204
Overall Study	COMPLETED	Placebo	185
Overall Study	COMPLETED	MD-120 50 mg	195
Overall Study	COMPLETED	MD-120 100 mg	186
Overall Study	NOT COMPLETED	Placebo	19
Overall Study	NOT COMPLETED	MD-120 50 mg	12
Overall Study	NOT COMPLETED	MD-120 100 mg	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04345471/flow